Zoya Gluzman

Health Technology

Consumer Services

Profile

Zoya Gluzman worked as a Principal at VESSL Therapeutics Ltd.
and as a Chief Technology Officer at GeneGrafts Ltd.
She holds an MBA and a doctorate degree from Technion-Israel Institute of Technology.

Former positions of Zoya Gluzman

Companies	Position	End
VESSL Therapeutics Ltd. VESSL Therapeutics Ltd. Medical SpecialtiesHealth Technology VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel.	Corporate Officer/Principal	-
GeneGrafts Ltd. GeneGrafts Ltd. BiotechnologyHealth Technology GeneGrafts Ltd. develops proprietary technology for modulating excitable tissues. Its technology is used for the treatment of cardiac arrhythmias, Parkinson's disease and other neurological disorders. The company was founded by Yair Feld, Lior Gepstein, Shimon Marom and Meira Melamed Frank in 2003 and is headquartered in Haifa, Israel.	Chief Tech/Sci/R&D Officer	-

See the detail of Zoya Gluzman's experience

Training of Zoya Gluzman

Technion-Israel Institute of Technology

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies